Variant report
Variant | nsv441895 |
---|---|
Chromosome Location | chr4:85083029-85089300 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17008216 | chr4:85083031-85083032 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs58819667 | chr4:85083039-85083040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72660850 | chr4:85083053-85083054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527407512 | chr4:85083073-85083074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554103811 | chr4:85083085-85083086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112738354 | chr4:85083103-85083104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192178261 | chr4:85083120-85083121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561454343 | chr4:85083155-85083156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2141807 | chr4:85083229-85083230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2141806 | chr4:85083231-85083232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373358703 | chr4:85083247-85083248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573261958 | chr4:85083257-85083258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs118121228 | chr4:85083275-85083276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553045372 | chr4:85083352-85083353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149417403 | chr4:85083395-85083396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551538128 | chr4:85083399-85083400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560055684 | chr4:85083400-85083401 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566733403 | chr4:85083412-85083413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147511776 | chr4:85083436-85083437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549457928 | chr4:85083475-85083476 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556052765 | chr4:85083477-85083478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184528477 | chr4:85083512-85083513 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538238474 | chr4:85083548-85083549 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550224479 | chr4:85083557-85083558 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113908282 | chr4:85083605-85083606 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571892667 | chr4:85083617-85083618 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373368817 | chr4:85083670-85083671 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76819884 | chr4:85083698-85083699 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113752168 | chr4:85083711-85083712 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536460898 | chr4:85083735-85083736 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs555036112 | chr4:85083768-85083769 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2868877 | chr4:85083860-85083861 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs573927725 | chr4:85083889-85083890 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542469393 | chr4:85083905-85083906 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9992688 | chr4:85083974-85083975 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs371071589 | chr4:85083992-85083993 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192605664 | chr4:85084004-85084005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544948094 | chr4:85084075-85084076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560405825 | chr4:85084080-85084081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373054450 | chr4:85084104-85084105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs147133136 | chr4:85084108-85084109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542888543 | chr4:85084115-85084116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs115237775 | chr4:85084133-85084134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs373108470 | chr4:85084220-85084221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550860037 | chr4:85084245-85084246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145311272 | chr4:85084369-85084370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184273217 | chr4:85084388-85084389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189093159 | chr4:85084410-85084411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs6843857 | chr4:85084417-85084418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532538201 | chr4:85084465-85084466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Prostate cancer | 16573809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:85080400-85084000 | Enhancers | Fetal Intestine Small | intestine |
2 | chr4:85081800-85083400 | Weak transcription | Fetal Intestine Large | intestine |
3 | chr4:85083200-85086400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr4:85083400-85083600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr4:85083400-85084000 | Enhancers | Fetal Intestine Large | intestine |
6 | chr4:85083600-85084000 | Bivalent Enhancer | Dnd41 | blood |
7 | chr4:85085000-85085400 | Enhancers | Fetal Lung | lung |
8 | chr4:85086400-85086600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr4:85086400-85086600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr4:85086400-85086800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr4:85086600-85088600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr4:85086600-85088600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr4:85088600-85089200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr4:85088600-85089400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |